What Should NSI Publish When a Hypothesis Produces No Effect?

The research question and what is observable

An experimental NSI hypothesis might predict that a prespecified physiological marker explains variation in compliance with a decision rule. If the observed effect is small, unstable or indistinguishable from zero within the study's uncertainty, the outcome is not a reason to hide the experiment. It may instead constrain what the framework can responsibly claim. The central question is what a null result establishes under a particular sample size and measurement design. Failure to reject a null hypothesis is not proof that no effect could exist in any population; it can nonetheless rule out large effects under sufficiently precise conditions. Scientific value depends on clear questions and transparent reporting rather than constant positivity.

The first methodological obligation is to separate a documented observation from the story attached to it. In this subject, negative results is an operational variable only when its source, time and unit are stated. It should not be used as a synonym for research transparency, because the two describe different layers of inference. A researcher must document when data became available, whether values were revised and which alternative explanations remain plausible. A result that seems persuasive after observing the outcome may not have been predictable beforehand. The goal is to establish a testable and appropriately limited claim, not to manufacture a directional conclusion.

Mechanism and competing explanations

Researcher flexibility can create a publication system in which only one of many possible analyses is displayed. Carp's study of methodological flexibility in fMRI documented how analytic decisions can proliferate [1]. Multi-team work by Botvinik-Nezer and colleagues demonstrated variation among analyses of the same dataset [2]. These findings are not specific to NSI, but they reveal why changing endpoints, filtering rules or subgroups until a positive result appears can make evidence look stronger than it is. A null result on a predefined primary outcome is therefore informative precisely because it resists this selective pathway.

Three different outcomes should not be collapsed into 'NSI failed.' The physiological measurement may not capture its proposed construct; a valid measurement may lack an association with the behavioral endpoint; or a real association may have no useful predictive value beyond a simpler baseline. Each conclusion suggests a different next experiment. A clear report should identify which of these questions was actually tested. It should also show attrition, missing measurements, exclusions and all prespecified outcomes. A narrow null finding does not invalidate every theory of human decision-making, but it prevents the tested relationship from being marketed as proven.

What the original evidence says

The reliability-paradox research by Hedge, Powell and Sumner demonstrates that strong experimental effects are not automatically useful for explaining individual differences [3]. A neurofinance experiment may detect an average response to a task yet fail to produce a stable person-level measure. If the intended application is assessment of trader state, that gap cannot be repaired by reporting only group significance. Conversely, a null result could reflect a noisy instrument, inadequate variation in the task or insufficient statistical power. Reporting measurement reliability and plausible effect ranges helps readers distinguish these explanations. Selectively suppressing nonsignificant outcomes would exaggerate confidence in the overall research program.

Interpretation should also distinguish the scale of the source material from the scale of the proposed use. An experimental study may identify a mechanism under controlled conditions, while an individual's financial decision is affected by changing incentives, competing information and execution constraints. If the objective is research on decision quality, outcomes should include process measures that can be evaluated without knowing whether the trade later won or lost. If the objective is market forecasting, entirely separate point-in-time records and out-of-sample tests are necessary. NSI should report both successful and unsuccessful tests, specify data provenance, and never present a conceptual framework as clinical diagnosis or proven market prediction.

How the hypothesis could be tested fairly

Before collecting data, define a primary outcome, a minimally important effect, a sampling plan and reasonable sensitivity analyses. Publish the protocol and any deviations with their dates. After analysis, report effect estimates, uncertainty intervals, sample characteristics, measurement reliability and the complete set of planned comparisons. Where possible, conduct independent replication with new people, sessions and market conditions. A useful public dashboard would count tests completed and negative as well as positive results, so readers can see the denominator rather than only successful case studies. Any future clinical or financial claim would need prospective validation beyond this exploratory stage.

Conclusion and limits

Negative results can improve a framework by narrowing unsupported possibilities. The relevant NSI archive entries A Repeatable Brain or Behavior Score Is Not Automatically a Useful Predictor and One Brain Dataset, Many Results show why reproducibility and interpretation are separate tasks. NSI remains a proposed interdisciplinary research framework; null outcomes should be a visible part of its development.